Dual effects of heparin on BMP-2-induced osteogenic activity in MC3T3-E1 cells

Pharmacological Reports

Volumn 63, Issue 5, 2011, Pages 1222-1230

  Kanzaki, Shin ^a   Ariyoshi, Wataru ^a   Takahashi, Tetsu ^a   Okinaga, Toshinori ^a   Kaneuji, Takeshi ^a   Mitsugi, Sho ^a   Nakashima, Keisuke ^a   Tsujisawa, Toshiyuki ^a   Nishihara, Tatsuji ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

BMP 2; Heparin; Osteoblast; Osterix; Runx2; Smad

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; HEPARIN; MESSENGER RNA; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 83155181917     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70642-9     Document Type: Article

References (38)

1. Ariyoshi W, Takahashi T, Kanno T, Ichimiya H, Takano H, Koseki T, Nishihara T: Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J Biol Chem, 2005, 280, 18967-18972. (Pubitemid 41379600)
2. Bessey OA, Lowry OH, Brock MJ: Amethod for the rapid determination of alkaline hosphatase with five cubic millimeter of serum. J Biol Chem, 1946, 163, 321-329.
3. Bi Y, Stuelten CH, Kilts T, Wadhwa S, Iozzo RV, Robey PG, Chen XD, Young MF: Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem, 2005, 280, 30481-30489. (Pubitemid 41216232)
4. Canalis E, Economides AN, Gazzerro E: Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev, 2003, 24, 218-235. (Pubitemid 36515285)
5. Cho KW, Blitz IL: BMPs, Smads and metalloproteases: extracellular and intracellular modes of negative regulation. Curr Opin Genet Dev, 1998, 8, 443-449. (Pubitemid 28412462)
6. Chowdhury MH, Hamada C, Dempster DW: Effects of heparin on osteoclast activity. J Bone Miner Res, 1992, 7, 771-777.
7. Folwarczna J, Śliwiński L, Janiec W, Pikul M: Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro. Pharmacol Rep, 2005, 57, 635-645.
8. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, DeRobertis EM: Intehrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell, 2007, 131, 980-993. (Pubitemid 350138081)
9. Holley RJ, Pickford CE, Rushton G, Lacaud G, Gallagher JT, Kouskoff V, Merry CL: Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparan and heparan sulfate saccharides. J Biol Chem, 2011, 286, 6241-6252.
10. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K: Smad6 inhibits signaling by the TGF-β superfamily. Nature, 1997, 389, 622-626. (Pubitemid 27446182)
11. Irie A, Habuchi H, Kimata K, Sanai Y: Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun, 2003, 308, 858-865. (Pubitemid 36976539)
12. Ito Y, Miyazono K: RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev, 2003, 13, 43-47. (Pubitemid 36143926)
13. Jeon O, Song SJ, Yang HS, Bhang SH, Kang SW, Sung MA, Lee JH, Kim BS: Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun, 2008, 369, 774-780.
14. Jiao X, Billings PC, O'Connell MP, Kaplan FS, Shore EM, Glaser DL: Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem, 2007, 282, 1080-1086. (Pubitemid 47076568)
15. Jones G, Sambrook PN: Drug-induced disorders of bone metabolism. Incidence, management and avoidance. Drug Saf, 1994, 10, 480-489.
16. Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tsujisawa T, Nishihara T: Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J Cell Physiol, 2008, 18, 447-454.
17. Kawano M, Ariyoshi W, Iwanaga K, Okinaga T, Habu M, Yoshioka I, Tominaga K, Nishihara T: Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid. Biochem Biophys Res Commun, 2011, 405, 575-580.
18. Lanaers-claeys G, Vaes G: Effects of heparin, parathyroid hormone and calcitonin. Biochem Biophys Acta, 1979, 584, 375-388.
19. Manton KJ, Leong DF, Cool SM, Nurcombe V: Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone orphogenetic protein signaling pathway. Stem Cells, 2007, 25, 2845-2854. (Pubitemid 350127869)
20. Miyazaki T, Miyauchi S, Tawada A, Anada T, Matsuzaka S, Suzuki O. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J Cell Physiol, 2008, 217, 769-777.
21. Nelson O, Jaime G, Teresa L, Francesc V, Enrique B. Sulfation is required for bone morphogenetic protein 2-dependent Id1 induction. Biochem Biophys Res Commun, 2006, 344, 1207-1215.
22. Ohkawara B, Iemura S, ten Dijke P, Ueno N: Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol, 2001, 12, 205-209. (Pubitemid 34122375)
23. Paine-Saunders S, Viviano BL, Economides AN, Saunders S: Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem, 2002, 277, 2089-2096. (Pubitemid 34968792)
24. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 2001, 29, e45.
25. Rasmussen TB, Uttenthal A, de Stricker K, Belak S, Storgaard T: Development of a novel quantitative realtime RT-PCR assay for the simultaneous detection of all serotypes of foot-and-mouth disease virus. Arch Virol, 2003, 148, 2005-2021. (Pubitemid 37284019)
26. Saisekharan R, Ernst S, Venkataraman G: On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans. Angiogenesis, 1997, 1, 45-54. (Pubitemid 127505701)
27. Sasisekharan R, Venkataraman G: Heparin and heparan sulfate: biosynthesis, structure and function. Curr Opin Chem Biol, 2000, 4, 626-631.
28. Shinmyouzu K, Takahashi T, Ariyoshi W, Ichimiya H, Kanzaki S, Nishihara T: Dermatan sulfate inhibits osteoclast formation by binding to receptor activator of NF-κB ligand. Biochem Biophys Res Commun, 2007, 354, 447-452. (Pubitemid 46164840)
29. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH et al.: A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell, 1999, 99, 13-22. (Pubitemid 29468626)
30. Shriver Z, Liu D, Saisekharan R: Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc Med, 2002, 12, 71-77. (Pubitemid 34145266)
31. Souchelnytskyi S, Nakayama T, Nakao A, Morèn A, Christian JL, ten Dijke P: Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-βreceptors. J Biol Chem, 1998, 273, 25364-25370. (Pubitemid 28443303)
32. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R: Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem, 2003, 278, 43229-43235. (Pubitemid 37345942)
33. Urist MR: Bone: formation by autoinduction. Science, 1965, 150, 893-899.
34. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M et al.: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med, 1999, 5, 793-802. (Pubitemid 29318614)
35. Waite KA, Eng C: From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nat Rev Genet, 2003, 4, 763-773. (Pubitemid 37193268)
36. Wolinsky-Friedland M: Drug-induced metabolic bone disease. Endocrinol Metab Clin North Am, 1995, 24, 395-420.
37. Wrana JL: Regulation of Smad activity. Cell, 2000, 100, 189-192.
38. Zhao B, Katagiri T, Toyoda H, Takada T, Yanai T, Fukuda T, Chung UI et al.: Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem, 2006, 281, 23246-23253.